Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

NKTRNKTR
5 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in Nektar Therapeutics

NORTHERN TRUST CORP holds 308,531 shares of NKTR (Nektar Therapeutics), worth $21.5M as of 2026-Q2. The position was increased (+292.5% shares). NKTR represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$21.5M

Current Shares

308,531

Total Value Change

+$20.9M

Total Shares Change

+284,387

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
308,531
+292.5%
$21.5M0.0%$69.81
46
2026-Q1
Increased
78,598
+40.2%
$5.7M0.0%$68.11
36
2025-Q4
Increased
56,076
+45.7%
$2.4M0.0%$41.90
35
2025-Q3
Increased
38,490
+59.4%
$2.2M0.0%$58.92
37
2025-Q2
New
24,144
-
$623,8810.0%$25.76
34

Other major holders of NKTR: FMR LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used